MREO vs WATR Comparison

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Air Water Ventures Ltd is a sustainable water solutions provider that produces drinking water by extracting humidity from the air. Its business includes premium packaged water sold in cans and bottles, manufacturing atmospheric water generators (AWGs) ranging from consumer to industrial scale, and operating water production and bottling facilities. The company has two reportable segments: bottling revenue and other revenue. Bottling revenue includes sales of packaged water, installation of bottling units at customer or own facilities, and supply of water via air-to-water generators to hospitality customers. Other revenue, the key revenue segment, includes sales of air-to-water generator machines, related maintenance and after-sales services, and leasing of air-to-water generator units.